264 related articles for article (PubMed ID: 8940213)
1. Immunogenicity of Neisseria gonorrhoeae lipooligosaccharide epitope 2C7, widely expressed in vivo with no immunochemical similarity to human glycosphingolipids.
Gulati S; McQuillen DP; Mandrell RE; Jani DB; Rice PA
J Infect Dis; 1996 Dec; 174(6):1223-37. PubMed ID: 8940213
[TBL] [Abstract][Full Text] [Related]
2. Experimental immunization with a monoclonal anti-idiotope antibody that mimics the Neisseria gonorrhoeae lipooligosaccharide epitope 2C7.
Gulati S; McQuillen DP; Sharon J; Rice PA
J Infect Dis; 1996 Dec; 174(6):1238-48. PubMed ID: 8940214
[TBL] [Abstract][Full Text] [Related]
3. Preclinical Efficacy of a Lipooligosaccharide Peptide Mimic Candidate Gonococcal Vaccine.
Gulati S; Pennington MW; Czerwinski A; Carter D; Zheng B; Nowak NA; DeOliveira RB; Shaughnessy J; Reed GW; Ram S; Rice PA
mBio; 2019 Nov; 10(6):. PubMed ID: 31690678
[TBL] [Abstract][Full Text] [Related]
4. Synthetic DNA Delivery of an Optimized and Engineered Monoclonal Antibody Provides Rapid and Prolonged Protection against Experimental Gonococcal Infection.
Parzych EM; Gulati S; Zheng B; Bah MA; Elliott STC; Chu JD; Nowak N; Reed GW; Beurskens FJ; Schuurman J; Rice PA; Weiner DB; Ram S
mBio; 2021 Mar; 12(2):. PubMed ID: 33727348
[TBL] [Abstract][Full Text] [Related]
5. Structural and immunochemical characterization of a Neisseria gonorrhoeae epitope defined by a monoclonal antibody 2C7; the antibody recognizes a conserved epitope on specific lipo-oligosaccharides in spite of the presence of human carbohydrate epitopes.
Yamasaki R; Koshino H; Kurono S; Nishinaka Y; McQuillen DP; Kume A; Gulati S; Rice PA
J Biol Chem; 1999 Dec; 274(51):36550-8. PubMed ID: 10593954
[TBL] [Abstract][Full Text] [Related]
6. Immunization against a saccharide epitope accelerates clearance of experimental gonococcal infection.
Gulati S; Zheng B; Reed GW; Su X; Cox AD; St Michael F; Stupak J; Lewis LA; Ram S; Rice PA
PLoS Pathog; 2013; 9(8):e1003559. PubMed ID: 24009500
[TBL] [Abstract][Full Text] [Related]
7. Bypassing Phase Variation of Lipooligosaccharide (LOS): Using Heptose 1 Glycan Mutants To Establish Widespread Efficacy of Gonococcal Anti-LOS Monoclonal Antibody 2C7.
Chakraborti S; Gulati S; Zheng B; Beurskens FJ; Schuurman J; Rice PA; Ram S
Infect Immun; 2020 Jan; 88(2):. PubMed ID: 31818965
[TBL] [Abstract][Full Text] [Related]
8. Complement alone drives efficacy of a chimeric antigonococcal monoclonal antibody.
Gulati S; Beurskens FJ; de Kreuk BJ; Roza M; Zheng B; DeOliveira RB; Shaughnessy J; Nowak NA; Taylor RP; Botto M; He X; Ingalls RR; Woodruff TM; Song WC; Schuurman J; Rice PA; Ram S
PLoS Biol; 2019 Jun; 17(6):e3000323. PubMed ID: 31216278
[TBL] [Abstract][Full Text] [Related]
9. Phase-Variable Heptose I Glycan Extensions Modulate Efficacy of 2C7 Vaccine Antibody Directed against Neisseria gonorrhoeae Lipooligosaccharide.
Chakraborti S; Lewis LA; Cox AD; St Michael F; Li J; Rice PA; Ram S
J Immunol; 2016 Jun; 196(11):4576-86. PubMed ID: 27183633
[TBL] [Abstract][Full Text] [Related]
10. Properdin is critical for antibody-dependent bactericidal activity against Neisseria gonorrhoeae that recruit C4b-binding protein.
Gulati S; Agarwal S; Vasudhev S; Rice PA; Ram S
J Immunol; 2012 Apr; 188(7):3416-25. PubMed ID: 22368277
[TBL] [Abstract][Full Text] [Related]
11. Strategies for mimicking Neisserial saccharide epitopes as vaccines.
Gulati S; Ngampasutadol J; Yamasaki R; McQuillen DP; Rice PA
Int Rev Immunol; 2001; 20(2):229-50. PubMed ID: 11878767
[TBL] [Abstract][Full Text] [Related]
12. Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine.
Gulati S; Shaughnessy J; Ram S; Rice PA
Front Immunol; 2019; 10():321. PubMed ID: 30873172
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a peptide vaccine candidate mimicking an oligosaccharide epitope of Neisseria gonorrhoeae and resultant immune responses and function.
Ngampasutadol J; Rice PA; Walsh MT; Gulati S
Vaccine; 2006 Jan; 24(2):157-70. PubMed ID: 16125281
[TBL] [Abstract][Full Text] [Related]
14. Antibody to reduction modifiable protein increases the bacterial burden and the duration of gonococcal infection in a mouse model.
Gulati S; Mu X; Zheng B; Reed GW; Ram S; Rice PA
J Infect Dis; 2015 Jul; 212(2):311-5. PubMed ID: 25596304
[TBL] [Abstract][Full Text] [Related]
15. Specificity of antibodies against Neisseria gonorrhoeae that stimulate neutrophil chemotaxis. Role of antibodies directed against lipooligosaccharides.
Densen P; Gulati S; Rice PA
J Clin Invest; 1987 Jul; 80(1):78-87. PubMed ID: 2439546
[TBL] [Abstract][Full Text] [Related]
16. A Novel Sialylation Site on Neisseria gonorrhoeae Lipooligosaccharide Links Heptose II Lactose Expression with Pathogenicity.
Ram S; Gulati S; Lewis LA; Chakraborti S; Zheng B; DeOliveira RB; Reed GW; Cox AD; Li J; St Michael F; Stupak J; Su XH; Saha S; Landig CS; Varki A; Rice PA
Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29844237
[TBL] [Abstract][Full Text] [Related]
17. Human vaccination with Escherichia coli J5 mutant induces cross-reactive bactericidal antibody against Neisseria gonorrhoeae lipooligosaccharide.
Dale PA; McQuillen DP; Gulati S; Rice PA
J Infect Dis; 1992 Aug; 166(2):316-25. PubMed ID: 1378871
[TBL] [Abstract][Full Text] [Related]
18.
Tzeng YL; Sannigrahi S; Borrow R; Stephens DS
Front Immunol; 2024; 15():1350344. PubMed ID: 38440731
[TBL] [Abstract][Full Text] [Related]
19. An essential saccharide binding domain for the mAb 2C7 established for Neisseria gonorrhoeae LOS by ES-MS and MSn.
Mühlecker W; Gulati S; McQuillen DP; Ram S; Rice PA; Reinhold VN
Glycobiology; 1999 Feb; 9(2):157-71. PubMed ID: 9949193
[TBL] [Abstract][Full Text] [Related]
20. Modification by sialic acid of Neisseria gonorrhoeae lipooligosaccharide epitope expression in human urethral exudates: an immunoelectron microscopic analysis.
Apicella MA; Mandrell RE; Shero M; Wilson ME; Griffiss JM; Brooks GF; Lammel C; Breen JF; Rice PA
J Infect Dis; 1990 Aug; 162(2):506-12. PubMed ID: 1695655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
